期刊文献+

阿霉素纳米粒对白血病多药耐药细胞株K562/ADR耐药性的逆转作用 被引量:3

Reversal effect of adriamycin-loaded nanoparticles on human leukemia multidrug -resisitant cell line K562/ADR
下载PDF
导出
摘要 目的 :研究阿霉素纳米粒对人白血病多药耐药细胞株K5 6 2 /ADR耐药性的逆转作用。方法 :采用MTT法测定药物的体外杀伤作用 ,应用流式细胞术测定细胞内药物浓度。结果 :阿霉素纳米粒和阿霉素对K5 6 2细胞细胞毒作用相似 ,K5 6 2 /ADR对阿霉素纳米粒较阿霉素敏感 2 .6 3倍 ,细胞内阿霉素浓度显著增加可能是关键因素。结论 OBJECTIVE To investigate reversal effect on human leukemia multidrug-resistant cell line K562/ADR by adriamycin-loaded nanoparticles.METHODS The reversal effect of the drugs on multidrug-resistant cell line were determin ed by MTT method.Intracellular accumulation of ADR was studied by flow cytometr y.RESULTS The cytotoxicity of adriamycin-loaded nanoparticles and free adriamycin was i dentical in K562 cells,but the chemosensitivity of K562/ADR cells to adriamycin -loaded nanoparticles was increased to 2.63 times compared with that of K56 2/ADR cells to free adriamycin.The increased sensitivity of K562/ADR cells to ad riamycin-loaded nanoparticles was due to a remarkable increasing intracellular accumulation of adriamycin.CONCLUSION Adriamycin-loaded nanoparticles reverse MDR effectively by increasing intracell ular accumulation of adriamycin in K562/ADR cells.
作者 王良才 柯红
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2004年第8期468-470,共3页 Chinese Journal of Hospital Pharmacy
关键词 阿霉素 聚氰基丙烯酸异丁酯 纳米粒 多药耐药 逆转 Adriamycin Polyisobutylcyanoacrylate Nanoparticles Multidrug resistance Reversal
  • 相关文献

参考文献10

  • 1Nooter K, Herweijer H. Multidrug resistance (mdr) genes in human cancer[J]. Br J Cancer, 1991,63:663.
  • 2Goren D, Horowitz AT, Tzemach D, et al. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump[ J ]. Clin Cancer Res, 2000,6 (5): 1949.
  • 3Couvreur P, Tulkens P, Rolland M, et al. Nanoparticles as a new type of lysosomotropic carrier[ J ]. FEBS Lett, 1977,84: 323.
  • 4Cuise V, Jaffray P, Delattre J, et al. Comparative cell uptake of iodide associated with liposomes or nanoparticles[J ]. Cell Mol Biol,1987,33: 397.
  • 5Colin DE, Veodiere A. Accumulation of doxorubicion from loaded nanoparticles in multidrug resistant leukemic murine cells [J ].Cancer Chemother Pharmacol, 1994,33: 501.
  • 6Cuvier C, Roblot L, Millot JM, et al. Doxorubicin-loaded nanospheres bypass cell mutidrug resistance[J ]. Biochem Pharmacol, 1992,44: 509.
  • 7Nemati F, Dubemet C, Colin DE, et al. Some parameters influencing cytotoxiclty of free doxorubicin and doxorubicin-Loaded nanoparticles in sensitive and multidrug resistant leukemic murine cells incubation time, number of nanopartides per cell [ J ]. Int
  • 8LI JK,Wan N,WU XS. Poly(vinylalcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery[J ].J Contr Release, 1998,56 (1-3): 117.
  • 9Tapiero H, Mishal Z,Wioland A, et al. Changes in biophysical parameters and in phospholipid composition associated with resistance to doxrubicin[ J ]. Anticancer Res, 1986,6: 649.
  • 10Kellen J A. The reveral of multidrug resistance in cancer [ J ]. Anticancer Res, 1993,13: 959.

共引文献1

同被引文献56

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部